As of close of business last night, Colgate-Palmolive Company’s stock clocked out at 74.90, down -0.35% from its previous closing price of $75.16. In other words, the price has decreased by $-0.26 from its previous closing price. On the day, 2873187 shares were traded. CL reached its highest trading level at $76.32 during the session, while it also had its lowest trading level at $74.89.
To gain a deeper understanding of CL’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 63.49 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 90.39. For the most recent quarter (mrq), Quick Ratio is recorded 0.70 and its Current Ratio is at 1.20. In the meantime, Its Debt-to-Equity ratio is 47.54 whereas as Long-Term Debt/Eq ratio is at 47.36.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on August 01, 2022, Upgraded its rating to Equal Weight and sets its target price to $80 from $71 previously.
On May 03, 2022, Atlantic Equities Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $92 to $80.
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 13 when Massey Sally sold 656 shares for $77.58 per share. The transaction valued at 50,890 led to the insider holds 7,913 shares of the business.
Parameswaran Prabha sold 48,778 shares of CL for $3,843,565 on Aug 29. The Grp Pres, Growth & Strategy now owns 6,787 shares after completing the transaction at $78.80 per share. On Aug 04, another insider, Daniels Jennifer, who serves as the CLO and Secretary of the company, sold 24,703 shares for $81.25 each. As a result, the insider received 2,007,176 and left with 48,163 shares of the company.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CL now has a Market Capitalization of 63.40B and an Enterprise Value of 70.53B. As of this moment, Colgate-Palmolive’s Price-to-Earnings (P/E) ratio for their current fiscal year is 32.49, and their Forward P/E ratio for the next fiscal year is 22.63. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 8.27. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.51 while its Price-to-Book (P/B) ratio in mrq is 374.50. Its current Enterprise Value per Revenue stands at 3.98 whereas that against EBITDA is 19.70.
Stock Price History:
The Beta on a monthly basis for CL is 0.47, which has changed by -2.31% over the last 52 weeks, in comparison to a change of -14.81% over the same period for the S&P500. Over the past 52 weeks, CL has reached a high of $85.61, while it has fallen to a 52-week low of $72.20. The 50-Day Moving Average of the stock is 78.92, while the 200-Day Moving Average is calculated to be 79.11.
It appears that CL traded 4.29M shares on average per day over the past three months and 5.02M shares per day over the past ten days. A total of 836.80M shares are outstanding, with a floating share count of 826.90M. Insiders hold about 0.10% of the company’s shares, while institutions hold 82.30% stake in the company. Shares short for CL as of Aug 30, 2022 were 13.32M with a Short Ratio of 3.10, compared to 13.81M on Jul 28, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.60% and a Short% of Float of 1.70%.
Dividends & Splits
With its trailing 12-month dividend rate of 1.84, CL has a forward annual dividend rate of 1.88. Against a Trailing Annual Dividend Yield of 2.45%, it implies a Forward Annual Dividend Yield of 2.50%. The stock’s 5-year Average Dividend Yield is 2.35. The current Payout Ratio is 78.70% for CL, which recently paid a dividend on Nov 14, 2022 with an ex-dividend date of Oct 19, 2022. Stock splits for the company last occurred on May 15, 2013 when the company split stock in a 2:1 ratio.
As of right now, 17 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.71 for the current quarter, with a high estimate of $0.73 and a low estimate of $0.68, while EPS last year was $0.8. The consensus estimate for the next quarter is $0.76, with high estimates of $0.82 and low estimates of $0.72.
Analysts are recommending an EPS of between $3.09 and $2.96 for the fiscal current year, implying an average EPS of $3.02. EPS for the following year is $3.28, with 21 analysts recommending between $3.55 and $3.01.
In the current quarter, 13 analysts expect revenue to total $4.35B. It ranges from a high estimate of $4.41B to a low estimate of $4.21B. As of the current estimate, Colgate-Palmolive Company’s year-ago sales were $4.25B, an estimated increase of 2.50% from the year-ago figure. For the next quarter, 13 analysts are estimating revenue of $4.48B, an increase of 1.50% less than the figure of $2.50% in the same quarter last year. There is a high estimate of $4.53B for the next quarter, whereas the lowest estimate is $4.39B.
A total of 19 analysts have provided revenue estimates for CL’s current fiscal year. The highest revenue estimate was $18.06B, while the lowest revenue estimate was $17.5B, resulting in an average revenue estimate of $17.81B. In the same quarter a year ago, actual revenue was $17.42B, up 2.20% from the average estimate. Based on 19 analysts’ estimates, the company’s revenue will be $18.29B in the next fiscal year. The high estimate is $18.6B and the low estimate is $17.51B. The average revenue growth estimate for next year is up 2.70% from the average revenue estimate for this year.